Conavi Medical Inks $100K Digital Marketing Deal with Winning Media

For marketing and adtech professionals, Conavi Medical's agreement offers a real-world case study of how a microcap public company allocates a modest six-figure budget across eight distinct digital channels rather than a single agency retainer.

Conavi Medical, a TSX Venture Exchange-listed medical device company, announced on September 4, 2026, that it had entered into a 12-month digital marketing services agreement with Houston-based Winning Media LLC, committing US$100,000 over the term. The arrangement, which is subject to acceptance by the TSX Venture Exchange, covers programmatic advertising, financial content distribution, influencer outreach, native advertising, podcast placements, email and SMS campaigns, and other online initiatives intended to increase market awareness. According to the company's release, no securities will be issued to Winning Media as compensation, and the vendor and its principals are arm's length to Conavi, even though Winning Media already owns 705,100 common shares of the company.

“

Conavi Medical, a TSX Venture Exchange-listed medical device company, announced on September 4, 2026, that it had entered into a 12-month digital marketing services agreement with Houston-based Winning Media LLC, committing US$100,000 over the term.

The deal fits a well-worn pattern among microcap issuers, which often use third-party digital marketing firms to broaden retail investor visibility. Its structure is notable for what it excludes: no stock-based compensation, no warrants, and no success fees tied to share-price performance. Instead, Conavi is paying a fixed monthly fee of roughly US$8,333, creating a predictable cash arrangement that avoids shareholder dilution but still consumes working capital. The fixed fee also makes the arrangement less dependent on audience outcomes, which can be both a benefit and a weakness: the company pays regardless of engagement, but the marketing firm has no incentive to inflate share price through aggressive promotion because it receives no stock or options.

Winning Media's service list reads like a catalog of current retail-investor marketing tactics. Programmatic advertising can place banner and video inventory at scale; native advertising blurs the line between editorial and promotion; influencer outreach and podcast placements aim at niche audiences; and email and SMS campaigns attempt to convert attention into engagement. For a medical device issuer with potentially thin trading liquidity, such campaigns can raise visibility, but they also raise a familiar microcap question: whether the awareness generated translates into durable institutional or strategic ownership rather than transient retail volume.

Because Conavi operates in the medical device sector, the campaign's framing matters. The release describes the goal as increasing market awareness of the company, not as direct-to-patient promotion of a specific device. That distinction is legally significant. Medical device promotion in the United States, Canada, and other jurisdictions is heavily regulated, with constraints on claims about safety, efficacy, and regulatory clearance. An investor-awareness program that sticks to already-disclosed, accurate corporate information is generally permissible, but any drift into unapproved product claims could create regulatory exposure. The requirement for TSXV acceptance also underscores the exchange's interest in supervising promotional arrangements and third-party compensation.

Financially, US$100,000 is modest by mid- or large-cap standards but can be material for a microcap. The release does not disclose Conavi's cash balance, burn rate, or market capitalization, so outside observers cannot judge how significant the expense is without consulting the company's financial statements. The fact that Winning Media is based in Houston while Conavi is a Canadian issuer listed on the TSXV indicates a cross-border service relationship, which may warrant attention to securities-marketing rules in both jurisdictions. Existing shareholders may weigh the potential awareness benefit against the cost and the optics of paying a firm that already holds a stake. Winning Media's pre-existing 705,100-share position creates a nuanced alignment: the provider has equity exposure while also receiving cash fees, and the absence of new share issuance at least avoids incremental dilution.